204 results
Page 5 of 11
6-K
EX-99.1
9naoqf 1vknecdm2o
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.1
0gugt
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.2
7p1j ysjf47i0g
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.1
4548 xglyx1aarb
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
149v86ypn hqchkqjl
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
g3pmoig6 60eg7m
22 Apr 20
Replicel Postpones Filing of Annual Financial Statements and MD&A Due to COVID-19 Related Delays
1:56pm
6-K
EX-99.1
m6pv2u3526mp
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.1
kf6tx5 ogozcnja5
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.1
ow2xxf
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
zawyaoldsz prd
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
ys8jh9xeps97 omoae
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
kihz4zk7k
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.2
ol0jkkd7
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
d7jdryv8sknlfajkcl
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
75e0w7o je5m9jouxer
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
7936ho
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
9a6gxk56s3x4fo
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
iks bbdczyn7rlgg
6 Mar 19
51-102F3 Material Change Report
4:53pm